Researchers developed MultiPerturb-seq, a high-throughput CRISPR screening platform with joint single-nucleus chromatin accessibility, transcriptome, and guided RNA capture using combinatorial indexing combined with droplet microfluidics to scale throughput and integrate all three modalities.
[Nature Biotechnology]